The Venture Codex Logo

The Venture Codex

JDRF

200 Vesey Street, 28th Floor, New York, NY, 10281, United States

Overview

Accelerating breakthroughs in treating and preventing type 1 diabetes.

Deals · 12mo

1

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A

Geographic focus

Canada
France
Italy
United States

Sector focus

Non Profit

Investment portfolio

14rounds
NAMEDATESIZE
SyntaxBio
Dec 2025Led
$0.86 MGrant
Cour Pharmaceuticals Development
Jan 2024Participated
$105 MSeries A
DiogenX
May 2023Participated
$30 MSeries A
Inversago Pharma
Oct 2022Participated
$69 MSeries C
Kriya Therapeutics
Jul 2021Participated
$100 MSeries B
Abata Therapeutics
Jun 2021Participated
$95 MSeries A
Enthera
Jan 2021Participated
$42 MSeries A
Enthera
Jul 2020Participated
$33 MSeries A
DiogenX
Jun 2020Participated
$5 MSeed
Pandion Therapeutics
Apr 2020Participated
$80 MSeries B
SQZ Biotech
Aug 2018Participated
$72 MSeries C
Diasome Pharmaceuticals
Jul 2017Participated
$30 MOther Equity
SyntaxBio
Dec 2025Led
$0.86 MGrant
Cour Pharmaceuticals Development
Jan 2024Participated
$105 MSeries A
DiogenX
May 2023Participated
$30 MSeries A
Inversago Pharma
Oct 2022Participated
$69 MSeries C
Kriya Therapeutics
Jul 2021Participated
$100 MSeries B
Abata Therapeutics
Jun 2021Participated
$95 MSeries A
Enthera
Jan 2021Participated
$42 MSeries A
Enthera
Jul 2020Participated
$33 MSeries A
DiogenX
Jun 2020Participated
$5 MSeed
Pandion Therapeutics
Apr 2020Participated
$80 MSeries B
SQZ Biotech
Aug 2018Participated
$72 MSeries C
Diasome Pharmaceuticals
Jul 2017Participated
$30 MOther Equity
14
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

JDRF: 14 funding rounds are recorded in the selected participation categories.All available history.
JDRF: 14 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed01
Series A06
Series B02
Series C+02
Other Equity02
Grant10

Monthly Deal Activity

JDRF: 14 deals are recorded across 122 months.All available history.
JDRF: 14 deals are recorded across 122 months. All available history
MonthDeals
Sep '161
Oct '160
Nov '160
Dec '160
Jan '170
Feb '170
Mar '170
Apr '170
May '171
Jun '170
Jul '171
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '181
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '201
May '200
Jun '201
Jul '201
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '211
Feb '210
Mar '210
Apr '210
May '210
Jun '211
Jul '211
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '221
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '231
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '241
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '251
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

JDRF: Health & Life Sciences is the largest displayed sector by deal count (14 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

JDRF: Health & Life Sciences is the largest displayed sector by deal count (14 deals). All available history
SectorDeals
Health & Life Sciences14
Space & Frontier Tech1
Consumer & Lifestyle1

Deal Size Distribution

JDRF: 14 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

JDRF: 14 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M1
$10M-$25M1
$25M-$50M4
$50M-$100M4
$100M-$250M2
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

JDRF: United States has the largest recorded deal count among the displayed regions (9 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

JDRF: United States has the largest recorded deal count among the displayed regions (9 deals). All available history
RegionDeals
United States9
Europe4
Canada1
JDRF: 20 co-investors are shown, with Roche Venture sharing 4 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

JDRF: 20 co-investors are shown, with Roche Venture sharing 4 recorded deals. All available history
Co-investorShared deals
Roche Venture4
AbbVie Ventures2
Advent France Biotechnology2
Banca Profilo2
Banor SIM2
Boehringer Ingelheim2
Indaco Venture Partners2
Invus2
Pfizer2
Sofinnova Partners2
Access Biotechnology1
adMare BioInnovations1
Alpha Wave Ventures1
Alumni Ventures1
Amgen Ventures1
AmorChem1
Amplo1
Angelini Ventures1
Asset Management Partners1
Black Beret Life Sciences1

Investment Strategy

JDRF: Led accounts for 7% and participating for 93% of round participation.All available history.
JDRF: Led accounts for 7% and participating for 93% of round participation. All available history
CategoryDeals (count)Share (%)
Led17%
Participating1393%
JDRF: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
JDRF: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

Aaron J. Kowalski

President & Chief Executive Officer

Aaron Kowalski

Chief Mission Officer & Vice President, Research

Amanda Shand

Senior Development Officer

Anne Bergquist

Senior Vice President, Marketing and Communications

Cynthia Rice

Chief Mission Strategy Officer

Diane K Adams

Chancellor

Nicholas Mamrak
Red Maxwell

International Board of Directors

Richard Insel

Chief Scientific Officer, Research